Please login to the form below

Not currently logged in
Email:
Password:

Glyconics appoints CEO

Dr Kam Pooni joins the UK diagnostics firm

UK disease management diagnostics firm Glyconics has appointed Dr Kam Pooni as chief executive officer with immediate effect.

Dr Pooni succeeds current chief executive Dr Berwyn Clarke who becomes chairman, while Dr Mike Lewis moves from chairman to non-executive director.

With over 19 years experience in leading life science businesses, Dr Pooni joins Glyconics from Astellas Pharmaceutical Europe where he served as senior director of European commercial operations and effectiveness among other roles.

Dr Clarke said: “Kam is a proven leader, with an impressive combination of vision, passion and experience building and managing pharmaceutical businesses and will play a major role in the development of the business as well as bringing additional experience to the board.

“I look forward to working closely with him at this exciting stage of the company's development.”

11th November 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics